Ruurd C. Verheul

Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential

Nigel M. Stapleton, Jan Terje Andersen, Annette M. Stemerding et al. · Nature Communications · 2011 · 277 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide

Eleni Kourkouta, Rudie Weij, Anchel González‐Barriga et al. · Molecular Therapy — Nucleic Acids · 2019 · 61 citations · Full text

Life Sciences, Genetics, Neurology +17

Digital Droplet PCR for the Absolute Quantification of Exon Skipping Induced by Antisense Oligonucleotides in (Pre-)Clinical Development for Duchenne Muscular Dystrophy

Ruurd C. Verheul, J.C.T. van Deutekom, Nicole A. Datson · PLoS ONE · 2016 · 39 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +15

Cyclic Peptides to Improve Delivery and Exon Skipping of Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy

Silvana M.G. Jirka, Peter A.C. ’t Hoen, Valeriano Diaz Parillas et al. · Molecular Therapy · 2017 · 30 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +17

A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures

Monika Hiller, Maria Sofia Falzarano, Iker García et al. · PLoS ONE · 2018 · 28 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +13